BTSG vs. ZBH: BrightSpring Health Services vs. Zimmer Biomet Stock Comparison

Company Profile

BrightSpring Health Services (BTSG) and Zimmer Biomet (ZBH) both fall under the Health Care Equipment & Services industry group, but BTSG is classified in Health Care Providers & Services while ZBH is classified in Health Care Equipment & Supplies.

Zimmer Biomet (ZBH) carries decades of public-market history since July 25, 2001, while BrightSpring Health Services (BTSG) listed on January 26, 2024 — long-window comparisons have far more historical data on the ZBH side.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

BrightSpring Health Services (BTSG) has an aggressive beta of 1.75, indicating higher sensitivity to broad-market moves, while Zimmer Biomet (ZBH) is defensive at 0.42 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

BrightSpring Health Services (BTSG) at 15.54% sits in the top ROE quartile, while Zimmer Biomet (ZBH) at 6.03% is closer to the peer norm — stronger capital efficiency for BTSG.

Both BrightSpring Health Services (BTSG) at 2.69% and Zimmer Biomet (ZBH) at 8.95% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Zimmer Biomet (ZBH) at 17.35% operates in the top operating margin quartile, ahead of BrightSpring Health Services (BTSG) at 3.81%, which runs around its industry’s norm.

Profitability Metrics

Growth

BrightSpring Health Services (BTSG) at 28.18% sits in the top revenue growth quartile, while Zimmer Biomet (ZBH) at 7.20% is closer to the peer norm — faster top-line expansion for BTSG.

Only one side can be read here: Zimmer Biomet (ZBH) reports EPS growth of -19.86%, ranked against its industry; BrightSpring Health Services (BTSG) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Both BrightSpring Health Services (BTSG) at 1.62 and Zimmer Biomet (ZBH) at 1.46 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Zimmer Biomet (ZBH) at 0.60 carries an industry-typical debt-to-equity mix, while BrightSpring Health Services (BTSG) at 1.09 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

BrightSpring Health Services (BTSG) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Zimmer Biomet (ZBH) reports a yield of 0.90%, ranking against industry peers normally.

BrightSpring Health Services (BTSG) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Zimmer Biomet (ZBH) reports a payout of 24.24%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both BrightSpring Health Services (BTSG) at 47.62 and Zimmer Biomet (ZBH) at 26.66 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

BrightSpring Health Services (BTSG) at 0.88 sits in the cheaper P/S ratio quartile while Zimmer Biomet (ZBH) at 2.33 prices around its industry’s middle — BTSG costs less per dollar of sales, though read it alongside growth and margins.

Zimmer Biomet (ZBH) at 1.58 looks cheap against book in the lower P/B ratio quartile, while BrightSpring Health Services (BTSG) at 6.39 carries a premium in the upper quartile — a clear price-to-book gap.

Valuation Metrics